Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 1 1

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3Gastrointestinal 3Breast 3Thoracic 1Sarcoma 1Other solid neoplasm 1Lymphoid 1Head & Neck 1Gynecologic 1CNS 1

Conditions

Fasting 2Colorectal Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Solitary Fibrous Tumors 1Sarcoma 1Liposarcoma 1Intermittent Fasting 1Histiocytoma, Malignant Fibrous 1Fibrosis 1Esophageal Neoplasms 1Dermatofibrosarcoma 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Oxaliplatin 1413Fluorouracil 1301Capecitabine 1087Gemcitabine 1045Leucovorin 932Irinotecan 818Bevacizumab 804Cisplatin 669Radiotherapy 536Cetuximab 470pembrolizumab 428Paclitaxel 390Nivolumab 337130-nm albumin-bound paclitaxel 325Drug Therapy 314Docetaxel 287S 1 (combination) 274Sorafenib 266Folfox protocol 261Albumin-Bound Paclitaxel 259sintilimab 211durvalumab 210Surgical Procedures, Operative 204tislelizumab 203Radiosurgery 202lenvatinib 201apatinib 200Carboplatin 187Magnetic Resonance Spectroscopy 183regorafenib 181

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Angptl4 protein, mouse × Gastrointestinal × Clear all
NCT06789172 2026-05-22

INVOKE

Epkin

Phase 1 Recruiting
166 enrolled
GastrointestinalHead & NeckSarcomaThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Liposarcoma, Sarcoma, Colorectal Neoplasms, Dermatofibrosarcoma, Histiocytoma, Malignant Fibrous, Solitary Fibrous Tumors

NCT04247464 2023-10-05

CHEMOFAST

IMDEA Food

Phase NA Completed
11 enrolled
Gastrointestinal

Intermittent Fasting, Fasting, Colorectal Neoplasms

NCT03706846 2018-10-16

GASTROPREP

Centre Hospitalier Universitaire de Besancon

Phase NA Completed
70 enrolled
Gastrointestinal

Esophageal Neoplasms, Fasting, Fibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡